Natural history of colonization with vancomycin-resistant Enterococcus faecium. 1995

M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
Department of Medicine, New York Medical College, Valhalla 10595, USA.

OBJECTIVE To determine the incidence, duration, and genetic diversity of colonization with vancomycin-resistant Enterococcus faecium (VREF). METHODS Oncology unit of a 650-bed university hospital. METHODS Surveillance perianal swab cultures were performed on admission and weekly. The molecular relatedness of VREF isolates was determined by pulsed-field gel electrophoresis and by the hybridization pattern of the vanA resistance determinant. RESULTS During 8 months of surveillance, the VREF colonization rate was 16.6 patients per 1,000 patient-hospital days, which was 10.6 times greater than the VREF infection rate. Eighty-six patients with VREF colonization were identified. Colonization persisted for at least 7 weeks in the majority of patients. Of 36 colonized patients discharged from the hospital and then readmitted, an average of 2 1/2 weeks later, 22 (61%) patients still were colonized with VREF. Of the 14 patients who were VREF-negative at readmission, only three patients remained culture-negative throughout hospitalizations. PFGE demonstrated that colonization with the same VREF isolate may persist for at least 1 year, and patients may be colonized with more than one strain of VREF. CONCLUSIONS VREF colonization is at least 10-fold more prevalent than infection among oncology patients. Colonization often persists throughout lengthy hospitalizations and may continue for long periods following hospitalization.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009518 New York State bounded on the north by Lake Ontario and Canada, on the east by Vermont, Massachusetts, and Connecticut, on the south by the Atlantic Ocean, New Jersey, and Pennsylvania, and on the west by Pennsylvania, Lake Erie, and Canada.
D010356 Patient Isolation The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection. Home Isolation,Isolation, Home,Isolation, Patient,Negative Pressure Isolation,Negative Pressure Patient Isolation
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
October 1997, Infection control and hospital epidemiology,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
August 1994, American journal of infection control,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
February 1999, Journal of clinical microbiology,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
July 1995, Archives of internal medicine,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
June 2000, Revista medica de Chile,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
May 2017, Cell host & microbe,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
January 2020, Open forum infectious diseases,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
June 1996, Antimicrobial agents and chemotherapy,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
February 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
M A Montecalvo, and H de Lencastre, and M Carraher, and C Gedris, and M Chung, and K VanHorn, and G P Wormser
June 2007, Medicina clinica,
Copied contents to your clipboard!